Sg Americas Securities, LLC Acelrx Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$1.25 - $2.77 $35,725 - $79,166	-28,580 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$1.18 - $1.98 $33,724 - $56,588	28,580 New	28,580 $35,000
Q3 2020 Nov 09, 2020	SELL	$1.01 - $1.81 $43,241 - $77,491	-42,813 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.03 - $1.69 $22,503 - $36,923	21,848 Added 104.21%	42,813 $52,000
Q1 2020 Apr 30, 2020	BUY	$0.76 - $2.07 $15,933 - $43,397	20,965 New	20,965 $25,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.